Decheng Capital’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
JHC
Decheng Capital's NUVB Position: Q3 2026 in Review
Decheng Capital held its Nuvation Bio (NUVB) position steady in Q3 2026 at 25,954,439 shares worth $145M. The position accounts for 21.22% of the portfolio, ranked #2.
Decheng Capital first reported a position in NUVB in Q2 2024 and has held it in 10 quarters since. The position peaked at $233M in Q4 2025. 258 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.
- Decheng Capital held 25,954,439 shares of Nuvation Bio worth $145M as of Q3 2026.
- Decheng Capital left its Nuvation Bio share count unchanged in Q3 2026.
- Nuvation Bio made up 21.22% of Decheng Capital's portfolio in Q3 2026, its #2 holding.
- Decheng Capital first reported a position in Nuvation Bio in Q2 2024 and has held it in 10 quarters since.
- Decheng Capital's Nuvation Bio position peaked at $233M in Q4 2025.
- 258 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.
Based on Decheng Capital's 13F filing for Q3 2026, filed 13 Nov 2026.